The anxiety caused by abnormal results of Down syndrome screening tests

References

• Bangsgaard L, Tabor A. 2013. Do pregnant women and their partners make an informed choice about first trimester risk assessment for down syndrome, and are they satisfied with the choice? Prenatal Diagnosis 33:146–152.
   PubMed Web of Science ®Google Scholar
• Bekker HL, Hewison J, Thornton JG. 2004. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for down syndrome: a randomised controlled trial. Prenatal Diagnosis 24:265–275.
   PubMed Web of Science ®Google Scholar
• Bekker HL, Legare F, Stacey D, O'Connor A, Lemyre L. 2003. Is anxiety a suitable measure of decision aid effectiveness: a systematic review? Patient Education and Counseling 50:255–262.
   PubMed Web of Science ®Google Scholar
• Bjorklund U, Marsk A, Levin C, Ohman SG. 2012. Audiovisual information affects informed choice and experience of information in antenatal down syndrome screening–a randomized controlled trial. Patient Education and Counseling 86:390–395.
   PubMed Web of Science ®Google Scholar
• Chiang HH, Chao YM, Yuh YS. 2007. The maternal self in pregnant women undergoing maternal serum screening. Journal of Clinical Nursing 16:1180–1185.
   PubMed Web of Science ®Google Scholar
• Designing and Developing the Survey Instrument. (2007). In Sue, V. M., & Ritter, L. A. Conducting online surveys. Thousand Oaks, CA: Sage Publications Ltd. pp. 59–87.
   Google Scholar
• Dunkel Schetter C, Tanner L. 2012. Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Current Opinion in Psychiatry 25:141–148.
   PubMed Web of Science ®Google Scholar
• Eiser JR. 1998. Communication and interpretation of risk. British Medical Bulletin 54:779–790.
   PubMed Web of Science ®Google Scholar
• Favre R, Duchange N, Vayssiere C, Kohler M, Bouffard N, Hunsinger MC, et al. 2007. How important is consent in maternal serum screening for down syndrome in France? Information and consent evaluation in maternal serum screening for down syndrome: a French study. Prenatal Diagnosis 27:197–205.
   PubMed Web of Science ®Google Scholar
• Galesic M, Garcia-Retamero R. 2010. Statistical numeracy for health: a cross-cultural comparison with probabilistic national samples. Archives of Internal Medicine 170:462–468.
   PubMed Web of Science ®Google Scholar
• Glazier R, Goel V, Holzapfel S, Summers A, Pugh P, Yeung M. 1997. Written patient information about triple-marker screening: a randomized, controlled trial. Obstetrics & Gynecology 90:769–774.
   PubMed Web of Science ®Google Scholar
• Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. 2004. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technology Assessment 8:Iii, ix-x, 1–109.
   Web of Science ®Google Scholar
• Kjellsson G, Clarke P, Gerdtham UG. 2014. Forgetting to remember or remembering to forget: a study of the recall period length in health care survey questions. Journal of Health Economics 35:34–46.
   PubMed Web of Science ®Google Scholar
• Lipkus IM, Samsa G, Rimer BK. 2001. General performance on a numeracy scale among highly educated samples. Medical Decision Making 21:37–44.
   PubMed Web of Science ®Google Scholar
• Macintosh MC, Brambati B, Chard T, Grudzinskas JG. 1993. Predicting fetal chromosome anomalies in the first trimester using pregnancy associated plasma protein-A: a comparison of statistical methods. Methods of Information in Medicine 32:175–179.
   PubMed Web of Science ®Google Scholar
• Madigan S, Oatley H, Racine N, Fearon RMP, Schumacher L, Akbari E, et al. 2018. A meta-analysis of maternal prenatal depression and anxiety on child socioemotional development. Journal of the American Academy of Child and Adolescent Psychiatry 57:645–657 e8.
   PubMed Web of Science ®Google Scholar
• Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. 2005. First-trimester or second-trimester screening, or both, for down's syndrome. The New England Journal of Medicine 353:2001–2011.
   PubMed Web of Science ®Google Scholar
• Marteau TM. 1989. Framing of information: its influence upon decisions of doctors and patients. British Journal of Social Psychology 28: 89–94.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Bekker H. 1992. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). The British Journal of Clinical Psychology 31:301–306.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, Shaw RW. 1992a. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenatal Diagnosis 12:205–214.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Johnston M, Shaw RW, Michie S, Kidd J, New M. 1989. The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. Journal of Psychosomatic Research 33:7–16.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Saidi G, Goodburn S, Lawton J, Michie S, Bobrow M. 2000. Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women. Prenatal Diagnosis 20:714–718.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Slack J, Kidd J, Shaw RW. 1992b. Presenting a routine screening test in antenatal care: practice observed. Public Health 106:131–141.
   PubMed Web of Science ®Google Scholar
• Martini J, Knappe S, Beesdo-Baum K, Lieb R, Wittchen HU. 2010. Anxiety disorders before birth and self-perceived distress during pregnancy: associations with maternal depression and obstetric, neonatal and early childhood outcomes. Early Human Development 86:305–310.
   PubMed Web of Science ®Google Scholar
• Ng CC, Lai FM, Yeo GS. 2004. Assessment of maternal anxiety levels before and after amniocentesis. Singapore Medical Journal 45:370–374.
   PubMedGoogle Scholar
• Peters E, Hart PS, Fraenkel L. 2011. Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions. Medical Decision Making 31:432–436.
   PubMed Web of Science ®Google Scholar
• Peters E, Hibbard J, Slovic P, Dieckmann N. 2007. Numeracy skill and the communication, comprehension, and use of risk-benefit information. Health Affairs 26:741–748.
   PubMed Web of Science ®Google Scholar
• Pinto TM, Caldas F, Nogueira-Silva C, Figueiredo B. 2017. Maternal depression and anxiety and fetal-neonatal growth. Jornal de Pediatria 93:452–459.
   PubMed Web of Science ®Google Scholar
• Sadler M. 1997. Serum screening for Down's syndrome: how much do health professionals know? British Journal of Obstetrics and Gynaecology 104:176–179.
   PubMedGoogle Scholar
• Santalahti P, Latikka AM, Ryynanen M, Hemminki E. 1996. Women's experiences of prenatal serum screening. Birth 23:101–107.
   PubMed Web of Science ®Google Scholar
• Shahhosseini Z, Pourasghar M, Khalilian A, Salehi F. 2015. A review of the effects of anxiety during pregnancy on children's health. Materia Socio-Medica 27:200–202.
   PubMedGoogle Scholar
• Sinayev A, Peters E, Tusler M, Fraenkel L. 2015. Presenting numeric information with percentages and descriptive risk labels: a randomized trial. Medical Decision Making 35:937–947.
   PubMed Web of Science ®Google Scholar
• Spencer K. 2001. Age related detection and false positive rates when screening for down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free BetahCG and PAPP-A. BJOG: An International Journal of Obstetrics and Gynaecology 108:1043–1046.
   PubMed Web of Science ®Google Scholar
• Statham H, Green J. 1993. Serum screening for down's syndrome: some women's experiences. BMJ 307:174–176.
   PubMed Web of Science ®Google Scholar
• Steurer J, Fischer JE, Bachmann LM, Koller M, Ter Riet G. 2002. Communicating accuracy of tests to general practitioners: a controlled study. BMJ 324:824–826.
   PubMedGoogle Scholar
• Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al. 2013. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Medical Informatics and Decision Making 13 Suppl 2:S7.
   PubMed Web of Science ®Google Scholar
• Van Gelder MM, Bretveld RW, Roeleveld N. 2010. Web-based questionnaires: the future in epidemiology? American Journal of Epidemiology 172:1292–1298.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. 1988. Maternal serum screening for down's syndrome in early pregnancy. BMJ 297:883–887.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Kennard A, Hackshaw A, Mcguire A. 1997. Antenatal screening for down's syndrome. Journal of Medical Screening 4:181–246.
   PubMedGoogle Scholar
• Waters EA, Weinstein ND, Colditz GA, Emmons K. 2006. Formats for improving risk communication in medical tradeoff decisions. Journal of Health Communication 11:167–182.
   PubMed Web of Science ®Google Scholar
• Wegier P, Shaffer VA. 2017. Aiding risk information learning through simulated experience (ARISE): using simulated outcomes to improve understanding of conditional probabilities in prenatal down syndrome screening. Patient Education and Counseling 100:1882–1889.
   PubMed Web of Science ®Google Scholar